Investigational Drug Service, Hillman Cancer Center — Pittsburgh, Pennsylvania

Investigational Drug Service, Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Drug Service, Hillman Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Service, Hillman Cancer Center?

Investigational Drug Service, Hillman Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Service, Hillman Cancer Center conducted?

Investigational Drug Service, Hillman Cancer Center has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer.

Is Investigational Drug Service, Hillman Cancer Center accredited by Crixeo Health?

Investigational Drug Service, Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Service, Hillman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.